Precipio, Inc. (PRPO) fundamentals score
Precipio is a healthcare biotechnology company with a mission to battle the systemic problem of disease misdiagnosis, by focusing on improving cancer diagnostics, particularly, hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation.
Laboratory Analytical Instruments · Technology · Listed on NASDAQ
Overall: 5.2 out of 10, Mixed fundamentals
- Growth: 4.9/10
- Profitability: 4.4/10
- Financial health: 5.7/10
- Earnings quality: 5.6/10
- Valuation: 5.9/10
Scores are calculated from Precipio, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Technology stocks
- Micron Technology, Inc. (MU): 9.0/10
- Broadcom Inc. (AVGO): 8.9/10
- Logitech International S.A. (LOGI): 8.8/10
- Applovin Corporation (APP): 8.7/10
- Cirrus Logic, Inc. (CRUS): 8.7/10
- Hamilton Beach Brands Holding Company (HBB): 8.7/10
- Nerdwallet, Inc. (NRDS): 8.7/10
- Sandisk Corporation (SNDK): 8.7/10